ArticleVaccine2020

An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis.

Sebastian Aston-Deaville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.